Furthermore, we conducted a survival relevance analysis across multiple cancer types, including progression-free survival (PFS) and disease-specific survival (DSS), to learn the relevance of XRCC1 gene expression levels to the survival prognosis of cancer patients. This evidence concerns the gene XRCC1 and cancer.